SCHEMBL5372185

SCHEMBL5372185

Cc1oc(-c2ccccc2)nc1CCOc1ccc(Cn2cc(CCC(=O)O)c(-c3ccccc3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.61
PPARA Q07869 11/20 0.61
FFAR1 O14842 1/20 0.60
PPARD Q03181 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382421 0.93 FFAR1 (0.71) PPARGPPARAFFAR1PPARD
SCHEMBL5380833 0.87 FFAR1 (0.65) PPARGPPARAFFAR1PPARD
SCHEMBL5377238 0.85 FFAR1 (0.65) PPARGPPARAFFAR1PPARD
SCHEMBL5397157 0.85 FFAR1 (0.59) PPARGPPARAFFAR1PPARD
SCHEMBL5387848 0.84 FFAR1 (0.59) PPARGPPARAFFAR1PPARD
SCHEMBL7897351 0.84 FFAR1 (0.83) PPARGPPARAFFAR1PPARD
SCHEMBL5392056 0.84 FFAR1 (0.58) PPARGPPARAFFAR1
SCHEMBL5372174 0.84 FFAR1 (0.58) PPARGPPARAFFAR1PPARD
SCHEMBL5380371 0.83 PPARG (0.60) PPARGPPARAFFAR1PPARD
SCHEMBL5380970 0.82 FFAR1 (0.58) PPARGPPARAFFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed
EP-1457490-A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity Takeda Chemical Industries, Ltd. (JP) 2004-09-15 EP disclosed
EP-1228067-B1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-07-14 EP disclosed